US 9714226
Hydrazide containing nuclear transport modulators and uses thereof
granted A61KA61K31/4196A61K31/4439
Quick answer
US patent 9714226 (Hydrazide containing nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4196, A61K31/4439, A61K31/454, A61K31/496